BICYCLO[3.2.1]OCTYL AMIDE DERIVATIVES AND USES OF SAME
申请人:Li Guiying
公开号:US20120190686A1
公开(公告)日:2012-07-26
The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I):
wherein L, R
1
and R
2
are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
BICYCLO[3.2.1.]OCTYL AMIDE DERIVATIVES AND USES OF SAME
申请人:H. Lundbeck A/S
公开号:US20150057289A1
公开(公告)日:2015-02-26
The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I):
wherein L, R
1
and R
2
are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
Bicyclo[3.2.1]octyl amide derivatives and uses of same
申请人:Li Guiying
公开号:US08921370B2
公开(公告)日:2014-12-30
The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I):
wherein L, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.
Bicyclo[3.2.1]octyl amide derivatives as allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5 or mGluR5) for the treatment of central nervous system (CNS) disorders
申请人:H. Lundbeck A/S
公开号:EP2654422B1
公开(公告)日:2017-08-02
Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same
申请人:H. Lundbeck A/S
公开号:US20170217950A1
公开(公告)日:2017-08-03
The present invention provides bicyclo[3.2.1]octyl amide derivatives of formula (I):
wherein L, R
1
and R
2
are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods using the same.